Tag Olaparib

Olaparib is an anti cancer medication used to treat prostate cancer, ovarian cancer, breast cancer, pancreatic cancer. It is sold under the brand name lynparza.

Breast Cancer, Ovarian Cancer

PARP Inhibitors in Ovarian and Breast Cancer Treatment

A PARP inhibitor is a cancer drug that blocks the activity of poly(ADP-ribose) polymerase (PARP), a protein crucial for DNA repair, leading to cell death in various cancers, including ovarian, breast, prostate, pancreatic, and fallopian tube cancers.